New program aims to ease fear of cancer recurrence in lymphoma survivors
NCT ID NCT05080166
First seen Feb 27, 2026 · Last updated Jun 23, 2026 · Updated 18 times
Summary
This study is testing a program called UPLYFT, designed to help lymphoma survivors manage their fear of cancer coming back. The program includes six sessions with tools and information to improve quality of life and reduce worry. Researchers are enrolling 74 lymphoma survivors who have completed first-line treatment and are in remission, to see if the program is feasible and acceptable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) - a behavioral intervention
What this could lead to
If successful, this could provide a structured program to help lymphoma survivors reduce anxiety and improve their quality of life after treatment.
What could go wrong
This is a small, early-stage pilot study focused on feasibility and acceptability, not on proving effectiveness. The program may not work for everyone or may need further refinement.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.